Anixa Biosciences Is Maintained at Buy by EF Hutton
Anixa Biosciences Price Target Maintained With a $10.00/Share by EF Hutton
Anixa Biosciences Analyst Ratings
H.C. Wainwright Maintains Anixa Biosciences(ANIX.US) With Buy Rating, Maintains Target Price $7
Buy Rating Affirmed for Anixa Biosciences Amid Promising CAR-T Therapy Trials and Stable Financials
Anixa Biosciences Analyst Ratings
Anixa Biosciences Price Target Maintained With a $7.00/Share by HC Wainwright & Co.
H.C. Wainwright Maintains Anixa Biosciences(ANIX.US) With Buy Rating, Maintains Target Price $7
Anixa Biosciences Analyst Ratings
Buy Rating Affirmed for Anixa Biosciences Amid Promising Cancer Therapy Trials
Anixa Biosciences Analyst Ratings
Anixa Biosciences Analyst Ratings
Anixa Biosciences: A Buy Rating on Strong Financials and Promising Oncology Advances
Analysts Conflicted on These Healthcare Names: Anixa Biosciences (ANIX) and InMode (INMD)
Anixa Biosciences Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Anixa Biosciences, Maintains $12 Price Target
Anixa Biosciences Analyst Ratings
Buy Rating for Anixa Biosciences Backed by Strong Patent Position and Promising CAR-T Therapy Trial Results
Analysts Offer Insights on Healthcare Companies: Anixa Biosciences (ANIX) and Amylyx Pharmaceuticals Inc (AMLX)
HC Wainwright & Co. Reiterates Buy on Anixa Biosciences, Maintains $12 Price Target
No Data
No Data